Synergy Pharmaceuticals (SGYP) PT Lowered to $2.50 at Citi
Tweet Send to a Friend
Citi analyst Liav Abraham lowered her price target on Synergy Pharmaceuticals (NASDAQ: SGYP) to $2.50 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
